From Name

From Email

To Name

To Email

Message

Cell therapy promising against angina from microvascular dysfunction

from MedPage Today

Cell therapy promising against angina from microvascular dysfunction MedPage Today A percutaneous dose of CD34-positive cells appeared to ease ischemia and improve symptoms in coronary microvascular dysfunction, the ESCaPE-CMD pilot study showed. Microvascular function as measured by coronary flow reserve (CFR) improved from a mean 2.08 at baseline to 2.68 at 6 months (P=0.0045), a "very remarkable improvement," Timothy Henry, MD, of The Christ Hospital in Cincinnati, reported at the virtual annual conference of the Society for Cardiovascular Angiography and Interventions (SCAI). READ MORE

more